NeuroSoV Company Profile, Contacts & Intelligence

NeuroSoV Overview

NeuroSoV is a privately held, pre-clinical stage biopharmaceutical company currently headquartered in Portugal with an established consortium of differentiated international partners. NeuroSoV is pioneering the research of disease-modifying treatments for devastating Neurological Disorders by leveraging the existing pathological mechanisms knowledge associated with these burdensome disorders of public health concern to develop innovative molecules with the potential to change the natural course of disease. Our proposed transformative approach relies on a multidisciplinary team aiming to boost Parkinson's Disease drug development to prevent disease progression. NeuroSoV's first lead candidate in development targets one of the main identified underlying Parkinson's Disease pathological mechanism with a differentiated reformulated technology with the promise to delay disease progression while enhancing patients quality of life bringing every single individual closer to their family and loved ones. We are focused on developing new small molecules which tackle the oxidative stress involved in PD, aiming to target NADPH oxidase 1 (NOX1), a known source of oxidative stress deleterious to dopaminergic neurons in PD, using an ionic liquid based NOX1 inhibitor (N1inh-IL).

Website

www.neurosov.com

Industry

Biotechnology Research

Founded

2020

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

NeuroSoV Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

NeuroSoV People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

NeuroSoV Workforce Composition

Seniority breakdown across 3 visible profiles.

Compare Similar Companies to NeuroSoV

Explore companies in related markets and compare their industry and employee estimates.